Hordenine improves Parkinsonian‐like motor deficits in mice and nematodes by activating dopamine D2 receptor‐mediated signaling
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7790 ↗At a glance
Journal article in Phytotherapy Research, 2023. Written by Hongli Li and 15 co-authors. Institution: Drug Discovery Laboratory, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Major MEDLINE topics: Neurodegenerative Diseases, Parkinson Disease. Cited 7 times so far (Crossref); 46 references. Funded by: Shanghai E-Research Institute of Bioactive Constituent in TCM plan.
Abstract (original language)
Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the striatum, leading to dopamine (DA) deficiency in the striatum and typical motor symptoms. A small molecule as a dietary supplement for PD would be ideal for practical reasons. Hordenine (HOR) is a phenolic phytochemical marketed as a dietary supplement found in cereals and germinated barley, as well as in beer, a widely consumed beverage. This study was aimed to identify HOR as a dopamine D2 receptor (DRD2) agonist in living cells, and investigate the alleviative effect and mechanism of HOR on PD‐like motor deficits in mice and nematodes. Our results firstly showed that HOR is an agonist of DRD2, but not DRD1, in living cells. Moreover, HOR could improve the locomotor dysfunction, gait, and postural imbalance in MPTP‐ or 6‐OHDA‐induced mice or Caenorhabditis elegans , and prevent α‐synuclein accumulation via the DRD2 pathway in C. elegans . Our results suggested that HOR could activate DRD2 to attenuate the PD‐like motor deficits, and provide scientific evidence for the safety and reliability of HOR as a dietary supplement.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Drug Discovery Laboratory, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Physiology, and Institute for Brain Sciences, School of Life Sciences, Nanjing University, Nanjing, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
ORCID profiles: Shengjie Fan, Xiaojun Wu, Cheng Huang
Funding
- Shanghai E-Research Institute of Bioactive Constituent in TCM plan
Cite
APA
Li, H., Gao, M., Chen, Z., Zhou, Z., Li, W., Zhang, X., Jiang, X., Luo, L., Li, F., Wang, G., Zhang, Y., Huang, X., Zhu, J., Fan, S., Wu, X., & Huang, C. (2023). Hordenine improves Parkinsonian‐like motor deficits in mice and nematodes by activating dopamine D2 receptor‐mediated signaling. Phytotherapy Research. https://doi.org/10.1002/ptr.7790
Vancouver
Li H, Gao M, Chen Z, Zhou Z, Li W, Zhang X, et al. Hordenine improves Parkinsonian‐like motor deficits in mice and nematodes by activating dopamine D2 receptor‐mediated signaling. Phytotherapy Research. 2023. doi:10.1002/ptr.7790
BibTeX
@article{Li2023,
author = {Li, Hongli and Gao, Min and Chen, Ziyu and Zhou, Zhenyu and Li, Wei and Zhang, Xiaoyang and Jiang, Xi and Luo, Lingling and Li, Fei and Wang, Gaorui and Zhang, Yu and Huang, Xingxu and Zhu, Jingning and Fan, Shengjie and Wu, Xiaojun and Huang, Cheng},
title = {Hordenine improves Parkinsonian‐like motor deficits in mice and nematodes by activating dopamine D2 receptor‐mediated signaling},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7790}
}
EUVIMED